Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: The ACHIEVE trial

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Casagrande, Sarah S ^a   Jerome, Gerald J ^b,c   Dalcin, Arlene T ^b   Dickerson, Faith B ^d   Anderson, Cheryl A ^a,e   Appel, Lawrence J ^a,b,e   Charleston, Jeanne ^e   Crum, Rosa M ^a,b,e,h   Young, Deborah R ^h   Guallar, Eliseo ^a,e   Frick, Kevin D ^e   Goldberg, Richard W ^f,g   Oefinger, Meghan ^b   Finkelstein, Joseph ^a,b,e   Gennusa III, Joseph V ^b   Fred Omojole, Oladapo ^b   Campbell, Leslie M ^b   Wang, Nae Yuh ^a,b   Daumit, Gail L ^a,b,e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TOWSON UNIVERSITY   (United States)

^d SHEPPARD PRATT HEALTH SYSTEM   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f VA Capitol Health Care Network   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; LIFESTYLE; MALE; MENTAL DISEASE; MENTAL PATIENT; OBESITY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RESPONSIBILITY; TREATMENT OUTCOME; UNITED STATES; WEIGHT REDUCTION; BEHAVIOR THERAPY; COMORBIDITY; EXERCISE; FOLLOW UP; GROUP THERAPY; HEALTH STATUS; MENTAL HEALTH SERVICE; METHODOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VOCATIONAL REHABILITATION;

ADULT; BEHAVIOR THERAPY; COMMUNITY MENTAL HEALTH SERVICES; COMORBIDITY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; MARYLAND; MENTAL DISORDERS; OBESITY; OVERWEIGHT; PSYCHOTHERAPY, GROUP; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REHABILITATION, VOCATIONAL; RESEARCH DESIGN; WEIGHT LOSS;

EID: 78649942452     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-108     Document Type: Article

References (73)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286:1195-200. 10.1001/jama.286.10.1195, 11559264.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-41. 10.1001/jama.2009.2014, 20071471.
3. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999, 156:1686-96.
4. Coodin S. Body mass index in persons with schizophrenia. Can J Psychiatry 2001, 46:549-55.
5. Daumit GL, Clark JM, Steinwachs DM, Graham CM, Lehman A, Ford DE. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis 2003, 191:799-805. 10.1097/01.nmd.0000100923.20188.2d, 14671456.
6. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968-77.
7. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993, 119:655-60.
8. Depression Guideline Panel Depression in Primary Care 1993, 2. Rockville, MD: AHCPR, Depression Guideline Panel.
9. Macritchie KAN, Geddes JR, Scott J, Haslam DRS, Goodwin GM. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder 2002, (Cochrane Review). The Cochrane Library.
10. Physical Activity and Health: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion 1996, 1-300.
11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997, 157:2413-46. 10.1001/archinte.157.21.2413, 9385294.
12. Katz D, Oconnell M, Yeh M-C, Nawaz H, Njike V, Anderson L, Cory S, Deitz W. Public Health Strategies for Preventing and Controlling Overweight and Obesity in School Worksite Settings. A report on Recommendation of the Task Force on Community Preventive Services. 2005, 1-16.
13. Satcher D. The Surgeon General's call to action to prevent and decrease overweight and obesity. 2001, 1-39.
14. Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE. Obesity Among Those with Mental Disorders: A National Institute of Mental Health Meeting Report. Am J Prev Med 2009, 36:341-350. 10.1016/j.amepre.2008.11.020, 19285199.
15. Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001, 161:685-93. 10.1001/archinte.161.5.685, 11231700.
16. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, Lin PH, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ, Proschan MA, Erlinger TP, Appel LJ. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006, 144:485-95.
17. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007, CD005148.
18. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Raczynski J, Brewer A, Singh B, Cohen J. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001, 134:1-11.
19. Svetkey LP, Harsha DW, Vollmer WM, Stevens VJ, Obarzanek E, Elmer PJ, Lin PH, Champagne C, Simons-Morton DG, Aickin M, Proschan MA, Appel LJ. PREMIER: A Clinical Trial of Comprehensive Lifestyle Modification for Blood Pressure Control: Rationale, Design and Baseline Characteristics. Annals of Epidemiology 2003, 13:1-10. 10.1016/S1047-2797(03)00006-1, 12547479.
20. Mueser KT, McGurk SR. Schizophrenia. Lancet 2004, 363:2063-72. 10.1016/S0140-6736(04)16458-1, 15207959.
21. Ball MP, Coons VB, Buchanan RW. A program for treating olanzapine-related weight gain. Psychiatr Serv 2001, 52:967-9. 10.1176/appi.ps.52.7.967, 11433117.
22. Kalarchian MA, Marcus MD, Levine MD, Haas GL, Greeno CG, Weissfeld LA, Qin L. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005, 66:1058-63. 10.4088/JCP.v66n0815, 16086623.
23. Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, Park BJ, Geun Oh C. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. J Clin Psychiatry 2006, 67:547-53. 10.4088/JCP.v67n0405, 16669719.
24. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry 2004, 65:471-7. 10.4088/JCP.v65n0404, 15119908.
25. Pendlebury J, Haddad P, Dursun S. Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results. Hum Psychopharmacol 2005, 20:447-8. 10.1002/hup.707, 16106486.
26. Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003, 54:1155-7. 10.1176/appi.ps.54.8.1155, 12883145.
27. Weber M, Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res 2006, 83:95-101. 10.1016/j.schres.2006.01.008, 16507343.
28. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O'Hanlon K, Griver K, Sirkin A, Jeste DV. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006, 86:36-44. 10.1016/j.schres.2006.05.010, 16842977.
29. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977, 31(1):42-48. 478990, 856370.
30. Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG. Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index. Drug Alcohol Depend 2007, 87:297-302. 10.1016/j.drugalcdep.2006.09.002, 17045423.
31. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig 2003, 7:2-7.
32. Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, Hesson LA, Osei SY, Kaplan R, Stunkard AJ. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005, 353:2111-20. 10.1056/NEJMoa050156, 16291981.
33. Bandura A. Social Foundations of thought and action: a social cognitive theory. 1986, 617. Social Learning Theory Englewood Cliffs, Hall P.
34. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the treatment of addictive behaviors. 1985, 558. Guilford clinical psychology and psychotherapy series. New York: Guildord Press.
35. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983, 51:390-5. 10.1037/0022-006X.51.3.390, 6863699.
36. Watson DL, Tharp RG. Self-directed behavior: Self-modification for personal adjustment. 1989, Monterey: Brooks/Cole Publishing Company.
37. International classification of functioning, disability and health: ICF. 2001, World Health Organization: Geneva.
38. Brandt EN, Pope AM. Enabling America: assessing the role of rehabilitation science and engineering. 1997, Washington, DC: National Academy Press.
39. Appel L, Champagne C, Harsha D, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR. Effects of Comprehensive Lifestyle Modification on Blood Pressure Control: Main results of the PREMIER Clinical Trial. JAMA 2003, 289:2083-2093. Writing Group of the PREMIER Collaborative Research Group, 10.1001/jama.289.16.2083, 12709466.
40. Anthony WA, Rogers ES, Cohen M, Davies RR. Relationships between psychiatric symptomatology, work skills, and future vocational performance. Psychiatr Serv 1995, 46:353-8.
41. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder?. Schizophr Bull 1999, 25:309-19.
42. Bellack AS, Bennett ME, Gearson JS. Behavioral Treatment for Substance Abuse Treatment in Schizophrenia (BTSAS). 2001, 1-197. Baltimore: University of Maryland School of Medicine.
43. Velligan DI, Bow-Thomas CC, Huntzinger C, Ritch J, Ledbetter N, Prihoda TJ, Miller AL. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. Am J Psychiatry 2000, 157:1317-23. 10.1176/appi.ajp.157.8.1317, 10910797.
44. Bellack AS. Psychosocial Behavior. 2003, Psychiatry London: Wiley, Tasman A, Kay J, Lieberman JA.
45. American Heart Association and National Heart L, and Blood Institute Exercise and Your Heart: A guide to physical activity. AHA 2001, American Heart Association and National Heart L, and Blood Institute.
46. McCullough ML, Karanja NM, Lin PH, Obarzanek E, Phillips KM, Laws RL, Vollmer WM, O'Connor EA, Champagne CM, Windhauser MM. Comparison of 4 nutrient databases with chemical composition data from the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc 1999, 99:S45-53. DASH Collaborative Research Group, 10.1016/S0002-8223(99)00416-2, 10450294.
47. Piantadosi S. Clinical Trials: A Methodologic Perspective. 2005, Baltimore, MD: Wiley Interscience.
48. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42:121-30. 10.2307/2531248, 3719049.
49. Stamler R, Stamler J, Gosch FC, Civinelli J, Fishman J, McKeever P, McDonald A, Dyer AR. Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. JAMA 1989, 262:1801-7. 10.1001/jama.262.13.1801, 2778913.
50. Fishman G. Monte Carlo: Concepts, Algorithms, and Applications. 1996, Springer: New Yorker.
51. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007, (1):CD005148.
52. Daumit GL, Dalcin AT, Jerome GJ, Young DR, Charleston J, Crum RM, Anthony C, Hayes JH, McCarron PB, Khaykin E, Appel LJ. A behavioral weight loss intervention for persons with serious mental illness in psychiatric rehabilitation centers. Int J Obes 2010,
53. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998, 279:839-46. TONE Collaborative Research Group, 10.1001/jama.279.11.839, 9515998.
54. Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, Johnson KC, Foreyt JP, Hill JO, Trence DL, Vitolins MZ. One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring) 2009, 17:713-22. 10.1038/oby.2008.637, 2690396, 19180071.
55. Hollis JF, Gullion CM, Stevens VJ, Brantley PJ, Appel LJ, Ard JD, Champagne CM, Dalcin A, Erlinger TP, Funk K, Laferriere D, Lin PH, Loria CM, Samuel-Hodge C, Vollmer WM, Svetkey LP. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med 2008, 35:118-26. 10.1016/j.amepre.2008.04.013, 2515566, 18617080.
56. Melamed Y, Stein-Reisner O, Gelkopf M, Levi G, Sivan T, Illevici G, Rosenberg R, Weizman A, Bleich A. Multi-modal weight control intervention for people with persistent mental disorders. Psychiatr Rehabil J 2008, 31(3):194-200. 10.2975/31.3.2008.194.200, 18194946.
57. Block G, Gillespie C, Rosenbaum EH, Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med 2007, 18(4):284-8.
58. Block G, Clifford C, Naughton MD, Henderson M, McAdams M. A brief dietary screen for high fat intake. Journal of Nutrition Education 1989, 21(5):199-207.
59. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35(8):1381-95. 10.1249/01.MSS.0000078924.61453.FB, 12900694.
60. Eisen SV, Normand SL, Belanger AJ, Spiro A, Esch D. The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care 2004, 42(12):1230-41. 10.1097/00005650-200412000-00010, 15550803.
61. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depression symptoms in 5 psychiatric populations: a validation study. Am J Epidemiol 1977, 106(3):203-14.
62. Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care 2000, 38(11):1141-50. 10.1097/00005650-200011000-00008, 11078054.
63. Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, Herrington SA, Hays RD, Kaplan RM, Ganiats TG, Feeny D, Kind P. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care 2007, 45(12):1162-70. 10.1097/MLR.0b013e31814848f1, 2647803, 18007166.
64. Kolotkin RL, Crosby RD, Corey-Lisle PK, Li H, Swanson JM. Performance of a weight-related measure of Quality of Life in a psychiatric sample. Qual Life Res 2006, 15(4):587-96. 10.1007/s11136-005-4627-4, 16688492.
65. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991, 32(6):705-14. 10.1016/0277-9536(91)90150-B, 2035047.
66. Sallis JF, Grossman RM, Pinski RB, Patterson TL, Nader PR. The development of scales to measure social support for diet and exercise behaviors. Prev Med 1987, 16(6):825-836. 10.1016/0091-7435(87)90022-3, 3432232.
67. Schwarzer R. Measurement of Perceived Self-Efficacy: Psychometric Scales for cross-cultural research. Berlin: Berlin, Forschung and der Freien Universitat 1993,
68. Clark MM, Abrams DB, Niaura RS, Eaton CA, Rossi JS. Self-efficacy in weight management. J Consult Clin Psychol 1991, 59(5):739-44. 10.1037/0022-006X.59.5.739, 1955608.
69. McAuley E. The role of efficacy cognitions in the prediction of exercise behavior in middle-aged adults. J Behav Med 1992, 15:65-88. 10.1007/BF00848378, 1583674.
70. Spitzer RL, Devlin M, Walsh BT, Hasin D, Wing R, Marcus M, Stunkard A, Wadden T, Yanovski S, Agras S, Mitchell J, Nonas C. Binge eating disorder: A multisite field trial of the diagnostic criteria. International Journal of Eating Disorders 1992, 11:191-203.
71. Mujahid MS, Diez Roux AV, Morenoff JD, Raghunathan T. Assessing the measurement properties of neighborhood scales: from psychometrics to ecometrics. Am J Epidemiol 2007, 165(8):858-67. 10.1093/aje/kwm040, 17329713.
72. Stalvey BT, Owsley C, Sloane ME, Ball K. The Life Space Questionnaire: A Measure of the Extent of Mobility of Older Adults. Journal of Applied Gerontology 1999, 18(4):460-78.
73. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(2):193-213. 10.1016/0165-1781(89)90047-4, 2748771.